These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 32862383)

  • 1. Cancer-testis Antigen OY-TES-1 Expression and Immunogenicity in Hepatocellular Carcinoma.
    Luo B; Yun X; Li J; Fan R; Guo WW; Liu C; Lin YD; Ge YY; Zeng X; Bi SQ; Nong WX; Zhang QM; Xie XX
    Curr Med Sci; 2020 Aug; 40(4):719-728. PubMed ID: 32862383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer testis antigen OY-TES-1 expression and serum immunogenicity in colorectal cancer: its relationship to clinicopathological parameters.
    Luo B; Yun X; Fan R; Lin YD; He SJ; Zhang QM; Mo FR; Chen F; Xiao SW; Xie XX
    Int J Clin Exp Pathol; 2013; 6(12):2835-45. PubMed ID: 24294369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of cancer/testis antigen OY-TES-1 attenuates malignant behaviors of hepatocellular carcinoma cells in vitro.
    Fu J; Luo B; Guo WW; Zhang QM; Shi L; Hu QP; Chen F; Xiao SW; Xie XX
    Int J Clin Exp Pathol; 2015; 8(7):7786-97. PubMed ID: 26339343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. OY-TES-1 expression and serum immunoreactivity in epithelial ovarian cancer.
    Tammela J; Uenaka A; Ono T; Noguchi Y; Jungbluth AA; Mhawech-Fauceglia P; Qian F; Schneider S; Sharma S; Driscoll D; Lele S; Old LJ; Nakayama E; Odunsi K
    Int J Oncol; 2006 Oct; 29(4):903-10. PubMed ID: 16964386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum immunoreactivity of cancer/testis antigen OY-TES-1 and its tissues expression in glioma.
    Li X; Yan J; Fan R; Luo B; Zhang Q; Lin Y; Zhou S; Luo G; Xie X; Xiao S
    Oncol Lett; 2017 May; 13(5):3080-3086. PubMed ID: 28529561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of an HLA-A24-restricted OY-TES-1 epitope recognized by cytotoxic T-cells.
    Okumura H; Noguchi Y; Uenaka A; Aji T; Ono T; Nakagawa K; Aoe M; Shimizu N; Nakayama E
    Microbiol Immunol; 2005; 49(11):1009-16. PubMed ID: 16301813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of proacrosin binding protein sp32 precursor as a human cancer/testis antigen.
    Ono T; Kurashige T; Harada N; Noguchi Y; Saika T; Niikawa N; Aoe M; Nakamura S; Higashi T; Hiraki A; Wada H; Kumon H; Old LJ; Nakayama E
    Proc Natl Acad Sci U S A; 2001 Mar; 98(6):3282-7. PubMed ID: 11248070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer testis antigen OY-TES-1: analysis of protein expression in ovarian cancer with tissue microarrays.
    Fan R; Huang W; Luo B; Zhang QM; Xiao SW; Xie XX
    Eur J Gynaecol Oncol; 2015; 36(3):298-303. PubMed ID: 26189257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Melanoma antigen-3 expression in human hepatocellular carcinoma].
    Cai S; Zhao H; Leng X; Cheng J; Gong S; Peng J; Cong X; Wang Y; Rui J; Hui Y; Du R; Chen W
    Zhonghua Wai Ke Za Zhi; 2000 Sep; 38(9):693-6. PubMed ID: 11832142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OY-TES-1 may regulate the malignant behavior of liver cancer via NANOG, CD9, CCND2 and CDCA3: a bioinformatic analysis combine with RNAi and oligonucleotide microarray.
    Hu Q; Fu J; Luo B; Huang M; Guo W; Lin Y; Xie X; Xiao S
    Oncol Rep; 2015 Apr; 33(4):1965-75. PubMed ID: 25673160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concordant expression of proto-oncogene promyelocytic leukemia and major histocompatibility antigen HLA class I in human hepatocellular carcinoma.
    Xia M; Zhang JQ; Shen YQ; Xu LH; Chen AQ; Miao FQ; Xie W
    Tissue Antigens; 2007 Oct; 70(4):272-82. PubMed ID: 17767548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
    Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
    Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential therapeutic value of dendritic cells loaded with NY‑ESO‑1 protein for the immunotherapy of advanced hepatocellular carcinoma.
    Chen Y; Huang A; Gao M; Yan Y; Zhang W
    Int J Mol Med; 2013 Dec; 32(6):1366-72. PubMed ID: 24085111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of cancer-testis antigens in hepatocellular carcinoma.
    Zhao L; Mou DC; Leng XS; Peng JR; Wang WX; Huang L; Li S; Zhu JY
    World J Gastroenterol; 2004 Jul; 10(14):2034-8. PubMed ID: 15237429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the nonclassical HLA class I and MICA/B molecules in human hepatocellular carcinoma.
    Chen A; Shen Y; Xia M; Xu L; Pan N; Yin Y; Miao F; Shen C; Xie W; Zhang J
    Neoplasma; 2011; 58(5):371-6. PubMed ID: 21744989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The expression and clinopathological significance of miR-130b in human hepatocellular carcinoma].
    Xu Q; Cai W; Zhang M; Liu Q; Liu X
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Mar; 32(3):387-92. PubMed ID: 26927562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [OCT4 expression in hepatocellular carcinoma and its clinical significance].
    Huang PZ; Lu CL; Li BK; Hong J; Huang L; Wang L; Zhang Y; Yuan YF
    Chin J Cancer; 2010 Jan; 29(1):111-16. PubMed ID: 20038322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression and clinical significance of hepatocellular cancer antigen genes in human hepatocellular carcinoma].
    Wang WX; Leng XS; Peng JR; Mu DC; Wang Y; Zhu JY; Du RY; Chen WF
    Zhonghua Wai Ke Za Zhi; 2003 Jul; 41(7):506-8. PubMed ID: 12921655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant human leucocyte antigen-G expression and its clinical relevance in hepatocellular carcinoma.
    Lin A; Chen HX; Zhu CC; Zhang X; Xu HH; Zhang JG; Wang Q; Zhou WJ; Yan WH
    J Cell Mol Med; 2010 Aug; 14(8):2162-71. PubMed ID: 19799650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NKD1 correlates with a poor prognosis and inhibits cell proliferation by inducing p53 expression in hepatocellular carcinoma.
    Zhang S; Li J; Wang X
    Tumour Biol; 2016 Oct; 37(10):14059-14067. PubMed ID: 27507614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.